Repositório PUCRS: Busca

Busca

Resultados 1-10 de 62 (Tempo de busca: 0.001 Segundos).

anterior
1
2
3
4
...
7
próximo

Resultados em Itens:

Data de publicação	Título	Autor(es)
2016	The Management of Immune-related Adverse Events Associated with Immune Checkpoint Blockade	André Poisl Fay; Raphael Brandao Moreira; Paulo R. S.Nunes Filho; Caroline Albuquerque; Barrios
2015	Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study	André Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA; TEL', GABRIELA H; MCKAY, RANA R; SONG, JIAXI; CARVO, INGRID; LAMPRON, MEGAN E; KAYMAKCALAN, MARINA D; POLI-DE-FIGUEIREDO, CARLOS E; BELLMUNT, JOAQUIM; HODI, F STEPHEN; FREEMAN, GORDON J; ELFIKY, AYMEN; CHOUEIRI, TONI K
2016	Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênio	STEFANI, STEPHEN; SASSE, ANDRÉ; André Poisl Fay; KIM, HELLEN; ABADI, MARCIA; TEICH, VANESSA; LOPES, GILBERTO
2016	Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma	DE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA; URUN, YUKSEL; CAROL, HALLIE A.; André Poisl Fay; SIGNORETTI, SABINA; KWIATKOWSKI, DAVID J.; MCDERMOTT, DAVID F.; FREEDMAN, MATTHEW; POMERANTZ, MARK M.; CHOUEIRI, TONI K.
2015	HER2 as a target in invasive urothelial carcinoma	BELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE; André Poisl Fay; PARK, RACHEL S.; RIESTER, MARKUS; SELVARAJAH, SHAMINI; BARLETTA, JUSTINE A.; BERMAN, DAVID M.; DE MUGA, SILVIA; SALIDO, MARTA; GALLARDO, ENRIQUE; ROJO, FEDERICO; GUANCIAL, ELIZABETH A.; BAMBURY, RICHARD; MULLANE, STEPHANIE A.; CHOUEIRI, TONI K.; LODA, MASSIMO; STACK, EDWARD; ROSENBERG, JONATHAN
2015	Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective	Stephen Doral Stefani; Vanessa Teich; André Poisl Fay; Marcia Abadi; Scott Flanders; Cat Bui; Andre Sasse
2017	Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials	MOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO; NUZZO, PIER V.; DE VELASCO, GUILLERMO; MALUF, FERNANDO C.; André Poisl Fay; BELLMUNT, JOAQUIM; CHOUEIRI, TONI K.; SCHUTZ, FABIO A.
2016	Quality of life of cancer patients on the wave of immunotherapy	RAMOS, FERNANDA B. PRUSKI; André Poisl Fay
2015	Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors	BELLMUNT, JOAQUIM; WERNER, LILLIAN; LEOW, JEFFREY J.; MULLANE, STEPHANIE A.; André Poisl Fay; RIESTER, MARKUS; VAN HUMMELEN, PAUL; TAPLIN, MARY-ELLEN; CHOUEIRI, TONI K.; VAN ALLEN, ELIEZER; ROSENBERG, JONATHAN
2018	Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database	André Poisl Fay; MCKAY, RANA R.; LIN, XUN; SIMANTOV, RONIT; CHOUEIRI, TONI K.